Gutaperka published a new study comparing six helper phospholipids in liposomal nanoparticles to determine their biological performance.
Published
Signal category
Research & Knowledge
Quote
“A new Materials Today Bio study from Jiahao Ge, Siyuan Tang and colleagues at Ren Ji Hospital and Shanghai Jiao Tong University School of Medicine, with collaborators from Hannover Medical School, compared six helper phospholipids while keeping the other LNP components and their molar ratios constant”
— Nicolas Moniotte|Gutaperka team
Company
Gutaperka
Turning science into solutions
- Industry
- Business Consulting and Services
- Company size
- 1 employees
GUTAPERKA supports biotech and pharmaceutical leadership teams in transforming complex science into clear, actionable strategy. We work with executive teams, venture builders, and public–private R&D programs to bridge the gap between innovation, organization, and delivery. Combining hands-on experience in R&D, process development, and executive management, we help leaders focus, align, and execute. GUTAPERKA takes its name from gutta-percha, a natural material once prized for its flexibility and insulating strength. It was discovered in 1843 by a Singapore-based surgeon, William Montgomerie, who realized that the milky latex used by local craftsmen could be molded when warm and hardened when cool: a natural polymer centuries ahead of its time. It symbolizes what the company stands for: connecting, protecting, and structuring complex systems so ideas can flow and perform.
Founded 2021